Aims: The study explores how speech measures may be linked to language profiles in participants with Alzheimer's disease (AD) and how these profiles could distinguish AD from changes associated with normal aging. Methods: We analysed simple sentences spoken by older adults with and without AD. Spectrographic analysis of temporal and acoustic characteristics was carried out using the Praat software. Results: We found that measures of speech, such as variations in the percentage of voice breaks, number of periods of voice, number of voice breaks, shimmer (amplitude perturbation quotient), and noise-to-harmonics ratio, characterise people with AD with an accuracy of 84.8%. Discussion: These measures offer a sensitive method of assessing spontaneous speech output in AD, and they discriminate well between people with AD and healthy older adults. This method of evaluation is a promising tool for AD diagnosis and prognosis, and it could be used as a dependent measure in clinical trials.

Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR: An English translation of Alzheimer's 1907 paper, ‘Über eine eigenartige Erkankung (sic) der Hirnrinde'. Clin Anat 1995;8:429-431.
Alzheimer A, Forstl H, Levy R: On certain peculiar diseases of old age. Hist Psychiatry 1991;2:71-101.
Hodges JR, Salmon DP, Butters N: Semantic memory impairment in Alzheimer's disease. Failure of access or degraded knowledge? Neuropsychologia 1992;30:301-314.
Caramelli P, Mansur LL, Nitrini R: Language and communication disorders in dementia of the Alzheimer type; in Stemmer B, Whitaker HA (eds): Handbook of Neurolinguistics. San Diego, Academic Press, 1998, pp 463-473.
Garrard P, Maloney LM, Hodges JR, Patterson K: The effects of very early Alzheimer's disease on the characteristics of writing by a renowned author. Brain 2005;128:250-260.
Forbes KE, Venneri A: Detecting subtle spontaneous language decline in early Alzheimer's disease with a picture description task. Neurol Sci 2005;26:243-254.
Lam LCW, Ho P, Lui VWC, Tam CWC: Reduced semantic fluency as an additional screening tool for subjects with questionable dementia. Dement Geriatr Cogn Disord 2006;22:159-164.
Mesulam M, Wicklund A, Johnson N, Rogalski E, Léger GC, Rademaker A: Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 2008;63:709-719.
Kemper S, Marquis J, Thompson M: Longitudinal change in language production: effects of aging and dementia on grammatical complexity and propositional content. Psychol Aging 2001;16:600-614.
Romero B, Kurz A: Deterioration of spontaneous speech in AD patients during a 1-year follow-up: homogeneity of profiles and factors associated with progression. Dement Geriatr Cogn Disord 1996;7:35-40.
Josephs KA, Whitwell JL, Duffy JR, Vanvoorst WA, Strand EA, Hu WT: Progressive aphasia secondary to Alzheimer disease versus FTLD pathology. Neurology 2008;70:25-34.
Croot K, Hodges JR, Xuereb J, Patterson K: Phonological and articulatory impairment in Alzheimer's disease: a case series. Brain Lang 2000;75:277-309.
Singh S, Bucks RS, Cuerden JM: Evaluation of an objective technique for analysing temporal variables in DAT spontaneous speech. Aphasiology 2001;15:571-583.
Wutzler A, Becker R, Lämmler G, Haverkamp W, Steinhagen-Thiessen E: The anticipatory proportion as an indicator of language impairment in early-stage cognitive disorder in the elderly. Dement Geriatr Cogn Disord 2013;36:300-309.
Ripich DN: Functional communication with AD patients: a caregiver training program. Alzheimer Dis Assoc Disord 1994;8:95-109.
Hoffmann I, Nemeth D, Dye CD, Pakaski M, Irinyi T, Kalma J: Temporal parameters of spontaneous speech in Alzheimer's disease. Int J Speech Lang Pathol 2010;12:29-34.
Forbes KE, Venneri A, Shanks MF: Distinct patterns of spontaneous speech deterioration: a mild predictor of Alzheimer's disease. Brain Cogn 2002;48:356-361.
Tosto G, Gasparini M, Lenzi GL, Bruno G: Prosodic impairment in Alzheimer's disease: assessment and clinical relevance. J Neuropsychiatry Clin Neurosci 2011;23:E21-E23.
Venneri A, Forbes-McKay KE, Shanks MF: Impoverishment of spontaneous language and the prediction of Alzheimer's disease. Brain 2005;128:E27.
Gabani K, Sherman M, Solorio T, Liu Y, Bedore L, Na EP: A corpus-based approach for the prediction of language impairment in monolingual English and Spanish-English bilingual children. Proc Human Lang Technol Conf Meet North Am Chap ACL (HLTNAACL), Boulder, 2009, pp 46-55.
Martínez-Sánchez F, Meilán JJG, García-Sevilla J, Carro J, Arana JM: Oral reading fluency analysis in patients with Alzheimer disease and asymptomatic control subjects. Neurologia 2013;28:325-331.
Meilán JJG, Martínez-Sánchez F, Carro J, Sánchez JA, Pérez E: Acoustic markers associated with impairment in language processing in Alzheimer's disease. Span J Psychol 2012;15:487-494.
Roark B, Mitchell M, Hosom JP, Hollingshead K, Kaye J: Spoken language derived measures for detecting mild cognitive impairment. IEEE Trans Audio Speech Lang Processing 2011;19:2081-2090.
Taler V, Baum SR, Chertkow H, Saumier D: Comprehension of grammatical and emotional prosody is impaired in Alzheimer's disease. Neuropsychology 2008;22:188-195.
Martínez-Sánchez F, Meilán JJG, Pérez E, Carro J, Arana JM: Expressive prosodic patterns in individuals with Alzheimer's disease. Psicothema 2012;2:16-21.
Parsa V, Jamieson DG: Interactions between speech coders and disordered speech. J Speech Commun 2003;40:365-385.
Boersma P, Weenink D: Praat: doing phonetics by computer (version 5.1.29). 2010.
Tatsuoka M: Multiple Analysis: Techniques for Educational and Psychological Research. New York, Wiley, 1971.
Fisher RA: The use of multiple measurements in taxonomic problems. Ann Eugen 1936;7:179-188.
Horley K, Reid A, Burnham D: Emotional prosody perception and production in dementia of the Alzheimer's type. J Speech Lang Hear Res 2010;53:1132-1146.
Taler V, Phillips NA: Language performance in Alzheimer's disease and mild cognitive impairment: a comparative review. J Clin Exp Neuropsychol 2007;1:1-56.
Kemper S, Greiner LH, Marquis JG, Prenovos K, Mitzner TL: Language decline across the life span: findings from the Nun Study. Psychol Aging 2001;16:227-239.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.